Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2016

29.01.2016 | Maternal-Fetal Medicine

Early induction of labor in high-risk intrahepatic cholestasis of pregnancy: what are the costs?

verfasst von: Anne Katrine Friberg, Vera Zingmark, Jens Lyndrup

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Induction of labor among pregnant women with high levels of total bile acid (TBA) is common among clinicians. We examined, if women with intrahepatic cholestasis of pregnancy (ICP) and TBA ≥ 40 μmol/l have a higher risk of maternal–fetal complications, when labor is induced at 37 weeks of gestation, compared with induction of labor at term in women with low-risk ICP.

Methods

Retrospective cohort study of 16,185 women delivering at Roskilde University Hospital in the period 2006–2011. Women with high-risk ICP (TBA ≥ 40 μmol/l) had labor induced at 37 weeks of gestation; women with low-risk ICP (TBA < 40 μmol/l) at term.

Outcomes

Mode of delivery, duration of induction procedures, highest level of TBA and alanine aminotransferase (ALT) and for the neonates: Apgar scores at 5 min, umbilical cord pHs and SBEs, NICU admissions and birthweights.

Results

The incidences of ICP was 1.2 % (95 % CI 1.05–1.39 %) altogether and for high-risk ICP 0.4 % (95 % CI 0.27–0.46 %). No difference was found in mode of delivery, length of induction of labor nor in neonatal outcomes, except for an expected difference in birthweight. In high-risk ICP, ALT was not raised in 10.3 % (95 % CI 2.5–18.2 %).

Conclusion

Early induction of labor at 37 weeks of gestation seems justified in high-risk ICP, as, except for abbreviating gestational age by 9 days with 296 g smaller babies, induction of labor was not followed by detectable maternal–fetal disadvantages and is favored by an expected major reduction in ICP stillbirth risk.
Fußnoten
1
Until November 25th 2009 the Reactionlab A/S—BIO-STAT Bile Acid kit (Cat.no. 495000) was used. The kit was calibrated by performing measurements in parallel with the laboratorium in Gothenburg that performed the analyses in the large Swedish prospective study by A. Glantz (1) and was accordingly corrected by a factor 40/30; later a Sentinel Bile Acids TBA (REF 6K9001) were used and calibrated against its standard.
 
Literatur
1.
Zurück zum Zitat Glantz A, Marschall HU, Mattsson LA (2004) Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40(2):467–474CrossRefPubMed Glantz A, Marschall HU, Mattsson LA (2004) Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40(2):467–474CrossRefPubMed
2.
Zurück zum Zitat Fisk NM, Storey GN (1988) Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 95(11):1137–1143CrossRefPubMed Fisk NM, Storey GN (1988) Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 95(11):1137–1143CrossRefPubMed
4.
Zurück zum Zitat Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT et al (1994) Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 170(3):890–895CrossRefPubMed Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT et al (1994) Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 170(3):890–895CrossRefPubMed
6.
Zurück zum Zitat Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C (2014) Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 59(4):1482–1491CrossRefPubMedPubMedCentral Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C (2014) Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 59(4):1482–1491CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Pata O, Vardareli E, Ozcan A, Serteser M, Unsal I, Saruc M et al (2011) Intrahepatic cholestasis of pregnancy: correlation of preterm delivery with bile acids. Turk J Gastroenterol 22(6):602–605CrossRefPubMed Pata O, Vardareli E, Ozcan A, Serteser M, Unsal I, Saruc M et al (2011) Intrahepatic cholestasis of pregnancy: correlation of preterm delivery with bile acids. Turk J Gastroenterol 22(6):602–605CrossRefPubMed
8.
Zurück zum Zitat Oztekin D, Aydal I, Oztekin O, Okcu S, Borekci R, Tinar S (2009) Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy. Arch Gynecol Obstet 280(6):975–979CrossRefPubMed Oztekin D, Aydal I, Oztekin O, Okcu S, Borekci R, Tinar S (2009) Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy. Arch Gynecol Obstet 280(6):975–979CrossRefPubMed
9.
Zurück zum Zitat Wikstrom Shemer E, Marschall HU, Ludvigsson JF, Stephansson O (2013) Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG 120(6):717–723CrossRefPubMed Wikstrom Shemer E, Marschall HU, Ludvigsson JF, Stephansson O (2013) Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG 120(6):717–723CrossRefPubMed
10.
Zurück zum Zitat Joutsiniemi T, Timonen S, Leino R, Palo P, Ekblad U (2014) Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial. Arch Gynecol Obstet 289(3):541–547CrossRefPubMed Joutsiniemi T, Timonen S, Leino R, Palo P, Ekblad U (2014) Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial. Arch Gynecol Obstet 289(3):541–547CrossRefPubMed
11.
Zurück zum Zitat Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG (2012) Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 344:e3799CrossRefPubMedPubMedCentral Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG (2012) Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 344:e3799CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Germain AM, Kato S, Carvajal JA, Valenzuela GJ, Valdes GL, Glasinovic JC (2003) Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol 189(2):577–582CrossRefPubMed Germain AM, Kato S, Carvajal JA, Valenzuela GJ, Valdes GL, Glasinovic JC (2003) Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol 189(2):577–582CrossRefPubMed
13.
Zurück zum Zitat Kondrackiene J, Beuers U, Zalinkevicius R, Tauschel HD, Gintautas V, Kupcinskas L (2007) Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol 13(46):6226–6230CrossRefPubMedPubMedCentral Kondrackiene J, Beuers U, Zalinkevicius R, Tauschel HD, Gintautas V, Kupcinskas L (2007) Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol 13(46):6226–6230CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Brouwers L, Koster MP, Page-Christiaens GC, Kemperman H, Boon J, Evers IM et al (2015) Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 212(1):100 e1–100 e7CrossRefPubMed Brouwers L, Koster MP, Page-Christiaens GC, Kemperman H, Boon J, Evers IM et al (2015) Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 212(1):100 e1–100 e7CrossRefPubMed
15.
Zurück zum Zitat Geenes VL, Lim YH, Bowman N, Tailor H, Dixon PH, Chambers J et al (2011) A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta 32(12):1026–1032CrossRefPubMed Geenes VL, Lim YH, Bowman N, Tailor H, Dixon PH, Chambers J et al (2011) A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta 32(12):1026–1032CrossRefPubMed
16.
Zurück zum Zitat Silver RM, Parker CB, Goldenberg R, Reddy UM, Dudley DJ, Saade GR et al (2014) Bile acids in a multicenter, population-based case-control study of stillbirth. Am J Obstet Gynecol 210:460.e1-9PubMed Silver RM, Parker CB, Goldenberg R, Reddy UM, Dudley DJ, Saade GR et al (2014) Bile acids in a multicenter, population-based case-control study of stillbirth. Am J Obstet Gynecol 210:460.e1-9PubMed
17.
Zurück zum Zitat Suri V, Jain R, Aggarwal N, Chawla YK, Kohli KK (2012) Usefulness of fetal monitoring in intrahepatic cholestasis of pregnancy: a prospective study. Arch Gynecol Obstet 286(6):1419–1424CrossRefPubMed Suri V, Jain R, Aggarwal N, Chawla YK, Kohli KK (2012) Usefulness of fetal monitoring in intrahepatic cholestasis of pregnancy: a prospective study. Arch Gynecol Obstet 286(6):1419–1424CrossRefPubMed
18.
Zurück zum Zitat Williamson C, Hems LM, Goulis DG, Walker I, Chambers J, Donaldson O et al (2004) Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 111(7):676–681CrossRefPubMed Williamson C, Hems LM, Goulis DG, Walker I, Chambers J, Donaldson O et al (2004) Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 111(7):676–681CrossRefPubMed
19.
Zurück zum Zitat Puljic A, Kim E, Page J, Esakoff T, Shaffer B, LaCoursiere DY et al (2015) The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. Am J Obstet Gynecol 212:667.e1-5PubMed Puljic A, Kim E, Page J, Esakoff T, Shaffer B, LaCoursiere DY et al (2015) The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. Am J Obstet Gynecol 212:667.e1-5PubMed
20.
Zurück zum Zitat Wikstrom Shemer EA, Thorsell M, Marschall HU, Kaijser M (2013) Risks of emergency cesarean section and fetal asphyxia after induction of labor in intrahepatic cholestasis of pregnancy: a hospital-based retrospective cohort study. Sex Reprod Health 4(1):17–22CrossRef Wikstrom Shemer EA, Thorsell M, Marschall HU, Kaijser M (2013) Risks of emergency cesarean section and fetal asphyxia after induction of labor in intrahepatic cholestasis of pregnancy: a hospital-based retrospective cohort study. Sex Reprod Health 4(1):17–22CrossRef
21.
Zurück zum Zitat Abedin P, Weaver JB, Egginton E (1999) Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 4(1–2):35–37CrossRefPubMed Abedin P, Weaver JB, Egginton E (1999) Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 4(1–2):35–37CrossRefPubMed
22.
Zurück zum Zitat Lee RH, Goodwin TM, Greenspoon J, Incerpi M (2006) The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 26(9):527–532CrossRefPubMed Lee RH, Goodwin TM, Greenspoon J, Incerpi M (2006) The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 26(9):527–532CrossRefPubMed
23.
Zurück zum Zitat Laatikainen T, Tulenheimo A (1984) Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 22(2):91–94CrossRefPubMed Laatikainen T, Tulenheimo A (1984) Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 22(2):91–94CrossRefPubMed
24.
Zurück zum Zitat Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM (1996) Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 175(4 Pt 1):957–960CrossRefPubMed Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM (1996) Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 175(4 Pt 1):957–960CrossRefPubMed
Metadaten
Titel
Early induction of labor in high-risk intrahepatic cholestasis of pregnancy: what are the costs?
verfasst von
Anne Katrine Friberg
Vera Zingmark
Jens Lyndrup
Publikationsdatum
29.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2016
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4019-8

Weitere Artikel der Ausgabe 4/2016

Archives of Gynecology and Obstetrics 4/2016 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.